EDAP TMS SA (EDAP) Stock Analysis

EDAP TMS SA (EDAP) is a publicly traded company in the HEALTHCARE sector. It trades at $4.32. This page summarizes the public market data, fundamentals, and frequently asked questions for EDAP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DISTRIBUTION

Exchange: NASDAQ

Key Metrics

• Price: $4.32

Market Sentiment

EDAP TMS SA currently has a Neutral sentiment score of 0.13.

About EDAP TMS SA

EDAP TMS SA is a pioneering company in the development and commercialization of minimally invasive medical devices, primarily dedicated to treating urological diseases. Based in Lyon, France, EDAP TMS leverages its innovative technology to deliver effective treatment solutions across global markets, including the United States and Asia. The company's commitment to enhancing patient outcomes through advanced medical technologies positions it as a significant player in the urology sector, addre...

GNG Research Analysis

GNG Research scores EDAP TMS SA (EDAP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EDAP.

Frequently Asked Questions

Does EDAP pay dividends?

EDAP TMS SA (EDAP) does not currently pay a regular dividend.